| Target Price | $249.90 |
| Price | $138.07 |
| Potential |
81.00%
register free of charge
|
| Number of Estimates | 43 |
|
43 Analysts have issued a price target Oracle 2027 .
The average Oracle target price is $249.90.
This is
81.00%
register free of charge
$420.00
204.19%
register free of charge
$111.10
19.53%
register free of charge
|
|
| A rating was issued by 49 analysts: 39 Analysts recommend Oracle to buy, 9 to hold and 1 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Oracle stock has an average upside potential 2027 of
81.00%
register free of charge
|
| May '26 |
2027 Estimates |
|
|---|---|---|
| Revenue Billion $ | 67.36 | 92.09 |
| 17.35% | 36.71% | |
| EBITDA Margin | 35.80% | 58.16% |
| 1.43% | 62.45% | |
| Net Margin | 25.21% | 27.28% |
| 16.32% | 8.19% |
45 Analysts have issued a sales forecast Oracle 2027 . The average Oracle sales estimate is
This results in the following potential growth metrics:
30 Analysts have issued an Oracle EBITDA forecast 2027. The average Oracle EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
45 Oracle Analysts have issued a net profit forecast 2027. The average Oracle net profit estimate is
This results in the following potential growth metrics and future Net Margins:
| May '26 |
2027 Estimates |
|
|---|---|---|
| Earnings Per Share $ | 5.82 | 8.31 |
| 34.10% | 42.78% | |
| P/E | 16.53 | |
| EV/Sales | 5.57 |
45 Analysts have issued a Oracle forecast for earnings per share. The average Oracle EPS is
This results in the following potential growth metrics and future valuations:
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Argus Research |
Locked
➜
Locked
|
Locked | Sep 14 2026 |
| Freedom Broker |
Locked
➜
Locked
|
Locked | Sep 14 2026 |
| Cantor Fitzgerald |
Locked
➜
Locked
|
Locked | Sep 11 2026 |
| Guggenheim |
Locked
➜
Locked
|
Locked | Sep 11 2026 |
| BMO Capital |
Locked
➜
Locked
|
Locked | Sep 11 2026 |
| DA Davidson |
Locked
➜
Locked
|
Locked | Sep 11 2026 |
| Barclays |
Locked
➜
Locked
|
Locked | Sep 11 2026 |
| Analyst Rating | Date |
|---|---|
|
Locked
Argus Research:
Locked
➜
Locked
|
Sep 14 2026 |
|
Locked
Freedom Broker:
Locked
➜
Locked
|
Sep 14 2026 |
|
Locked
Cantor Fitzgerald:
Locked
➜
Locked
|
Sep 11 2026 |
|
Locked
Guggenheim:
Locked
➜
Locked
|
Sep 11 2026 |
|
Locked
BMO Capital:
Locked
➜
Locked
|
Sep 11 2026 |
|
Locked
DA Davidson:
Locked
➜
Locked
|
Sep 11 2026 |
|
Locked
Barclays:
Locked
➜
Locked
|
Sep 11 2026 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


